Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments

Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments

MELBOURNE, Jan 16, 2024 – (ACN Newswire) – Prota Therapeutics Pty Ltd (Prota), an Australian biotechnology company focused on the development of novel oral immunotherapy treatments that induce remission of allergy, today announced financing of US$21 million in equity and debt financing. The round, led by Singapore-based SPRIM Global Investments (SGI…
Read More

Zaļā Josta - Reklāma